| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.12 | 0.09 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.23 | 0.1 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.3 | 0.1 |